30th June 2022 Today, Inizio Medical launches as a purpose-built portfolio of world-leading agencies and specialized services. Inizio Medical comprises three global medical communications agency groups, ApotheCom, Ashfield MedComms and Nucleus Global, that will be underpinned by the Specialized Services companies MEDiSTRAVA and MedEvoke.
The agency groups will continue to operate independently under the umbrella of Inizio Medical, providing a scale and a unique combination of capabilities and expertise never before seen in the life sciences industry.
Inizio Medical boasts an impressive global reach, with 29 offices in 13 countries, uniting more than 2,000 experts, with 700 PhDs among them, offering deep scientific knowledge across all therapeutic areas. Paired with powerful medical analytics capabilities, applied AI tools and multi-dimensional insights, the group can deliver extensive medical services across the entire product lifecycle. This combination of strategy and communications expertise now exist in Inizio Medical with the ultimate purpose of creating compelling content and engaging communities across the spectrum of healthcare.
Elaine Ferguson, Global President, Inizio Medical, said: “We have such an exciting opportunity. We are united by a vision to not only lead but redefine the role of Medical in drug development and commercialization. By bringing together our 2,000 plus experts, we can leverage their collective force and reimagine what we can do for our clients.
“Our clients are operating in far more complex therapeutic areas and the evidence burden of bringing a new medicine to market has increased. Now, as Inizio Medical we have the potential to build stronger relationships, pioneer new ways of partnership and mobilize the full capacity of our resources to put our power behind and overcome the biggest challenges our industry faces.”
Uniting the medical expertise and capabilities of Huntsworth, Nucleus and Ashfield, Inizio Medical is one of the five business units of Inizio. Combining complex scientific understanding with creativity, Inizio Medical creates compelling content and engages communities across the spectrum of healthcare.
Dan Bridges, Global Chief Executive Officer, Inizio Medical, added: “This really will set a new standard in the industry, and I am sure both our clients and our teams can’t wait to benefit from the broad skill sets and innovations that we have across Inizio Medical and the wider Inizio organization.
“We have already seen amazing collaboration between the groups even as this new company has come together. This provides absolute confidence that we will keep intact the leadership and cultures that make all our agency groups leaders in their field, whilst also providing an exciting, enhanced proposition to our clients and teams alike.”
Inizio Medical is one business unit of Inizio, a strategic partner to health and life science companies that offers a full suite of advisory, medical, marketing, communications, patient and stakeholder engagement services throughout the entire drug product life cycle.
Operating from 35 countries with a team of over 10,000 employees and an unparalleled number of strategic, scientific, medical and creative experts, Inizio connects the capabilities to support its clients with transformative go-to-market solutions across all therapeutic areas.